510(k) · Cleared
Recalled · Class I · 2023Hudson Rci Addipak Unit Dose Vial, 0.9% Full Normal Saline Solution, 3ML;5ML;15ML
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Teleflexmedical, Inc. · CAF Nebulizer (Direct Patient Interface)
Cleared on Apr 29, 2015 as substantially equivalent to K113033 (Nephron Pharmaceuticals Corp., 2012) after a 266-day review. Its family tree reaches back 3 generations to 1987. 1 of the 8 devices in its family, counting itself, has a Class I recall. 1 later device descends from it. It has been recalled once, including a Class I recall.
- Decided
- Apr 29, 2015
- Review
- 266 days
- Class
- Class II
- Product code
- CAF
- Recalls
- 1 (1 Class I)
- Predicates
- 1
Its longest line of descent runs back 3 generations to K870332 (1987). 6 ancestors in all, the oldest K840943 (1984). 1 later device descends from it, 1 citing it directly. 1 of the 8 devices in this family, counting this one, has a Class I recall.
- Root · 3 generations backK870332 Prefilled Respiratory Therapy VialsAutomatic Liquid Packaging, Inc. · 1987
- 2 generations backK972466 Sodium Chloride Inhalation Solution, UspHolopack International, LP · 1997
- 1 generation backK113033 Sodium Chlorde Inhalation Solution, 0.9% Usp-3MLNephron Pharmaceuticals Corp. · 2012
- This deviceK142153 Hudson Rci Addipak Unit Dose Vial, 0.9% Full Normal Saline Solution…Teleflexmedical, Inc. · 2015
- Descendant · cites it directly · 0 of its ownK231058 Hudson RCI® AddiPak® Unit Dose VialMedline Industries, LP · 2024
Most influential descendants
Showing 1 of 1 · See all- K231058Hudson RCI® AddiPak® Unit Dose VialMedline Industries, LP · 2024 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K870332 | Prefilled Respiratory Therapy Vials | Automatic Liquid Packaging, Inc. | 1987 | — |
| −2 | K972466 | Sodium Chloride Inhalation Solution, Usp | Holopack International, LP | 1997 | — |
| −1 | K113033 | Sodium Chlorde Inhalation Solution, 0.9% Usp-3ML | Nephron Pharmaceuticals Corp. | 2012 | — |
| 0 (this device) | K142153 | Hudson Rci Addipak Unit Dose Vial, 0.9% Full Normal Saline Solution… | Teleflexmedical, Inc. | 2015 | — |
| +1 | K231058 | Hudson RCI® AddiPak® Unit Dose Vial | Medline Industries, LP | 2024 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1984 | 1 | 0 |
| 1988 | 1 | 0 |
| 1998 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2024 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new CAF device
- #1 K260270 FindAir ONE for pMDI (FAO-MDI-V12-GRE-001)score 13.3 · 7 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K113033 | Sodium Chlorde Inhalation Solution, 0.9% Usp-3MLSummary page 5…dical, Inc. Pharmaceuticals 510(k) Number K142153 Pre-amendment K113033 The Hudson RCI® The Hudson RCI® Sterile, single use AddiPak® Unit Dos… | 2012 |
| * | — | Hudson RCI® AddiPak® Unit Dose Vial, 0.9% Full Normal Saline Solution Named without a submission number |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K231058 | Hudson RCI® AddiPak® Unit Dose Vial | 2024 | 0 |
Has anything in its family been recalled? (1 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Aug 4, 2023 | Class I | Z-2514-2023 | Process control | Product dispositioned for scrap for sterility failure investigation that was inadvertently shipped to customers. |
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 28 years and passes through 4 companies; a new generation was cleared every 10.4 years on median.
- None of the 6 ancestors has a recall.
- Of its descendants, K231058 (Medline Industries, LP, 2024) has gone furthest, with 0 descendants of its own.
- 1 other device also cites its predicate K113033.
How does its category compare?
All CAF devicesCAF Nebulizer (Direct Patient Interface): FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.
FDA decisions per year · CAF
7in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · CAF
211in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · CAF
1in 2018
Class I (13 since 2007) Class II/III not classified
Adverse event reports per year · CAF
191in 2025
MAUDE reports naming product code CAF, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 18 | 98 | 1 | 26 |
| 2008 | 12 | 123 | 0 | 11 |
| 2009 | 8 | 163 | 0 | 15 |
| 2010 | 10 | 114 | 0 | 37 |
| 2011 | 10 | 157 | 1 | 237 |
| 2012 | 9 | 126 | 0 | 138 |
| 2013 | 9 | 238 | 0 | 217 |
| 2014 | 9 | 151 | 5 | 123 |
| 2015 | 8 | 186 | 3 | 166 |
| 2016 | 5 | 186 | 1 | 201 |
| 2017 | 8 | 253 | 14 (13) | 256 |
| 2018 | 9 | 161 | 1 | 162 |
| 2019 | 3 | 266 | 0 | 185 |
| 2020 | 6 | 219 | 0 | 117 |
| 2021 | 8 | 324 | 0 | 161 |
| 2022 | 4 | 176 | 0 | 55 |
| 2023 | 8 | 279 | 0 | 107 |
| 2024 | 4 | 251 | 0 | 102 |
| 2025 | 7 | 211 | 0 | 191 |
| 2026 | 2 | — | 0 | — |
What is it indicated for?
The Hudson RCI® AddiPak® Unit Dose Vial, 0.9% Full Normal Saline Solution may be used in conjunction with a non-ventilatory nebulizer for lavage therapy, or for tracheal irrigation.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K142153 · printed Nov 3, 2026
Cite this page
510(k) Report. “K142153: Hudson Rci Addipak Unit Dose Vial, 0.9% Full Normal Saline Solution, 3ML;5ML;15ML.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K142153
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026